Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma

This publication has 24 references indexed in Scilit:

• Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation
  British Journal of Cancer, 1997
• Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV
  Oncogene, 1997
• Immunohistochemical localization of p21WAF1/CIP1 in normal, hyperplastic, and neoplastic uterine tissues
  Human Pathology, 1997
• EXPRESSION OF CYCLIN-DEPENDENT KINASE INHIBITOR p21WAF1/CIP1 IN NON-NEOPLASTIC MUCOSA AND NEOPLASIA OF THE STOMACH: RELATIONSHIP WITH p53 STATUS AND PROLIFERATIVE ACTIVITY
  The Journal of Pathology, 1996
• Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis
  International Journal of Cancer, 1996
• CDKN2 in HPV‐positive and HPV‐negative cervical‐carcinoma cell lines
  International Journal of Cancer, 1995
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
  Nature Genetics, 1994
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
  Published by Elsevier ,1994
• The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
  Nature, 1994
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
  Nature, 1993